General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Statements of Cash Flows

v2.3.0.11
Condensed Consolidated Statements of Cash Flows (USD $)
 9 Months Ended 12 Months Ended 0 Months Ended
Jul. 03, 2011
Jun. 27, 2010
Sep. 27, 2009
Successor [Member]
Oct. 03, 2010
Successor [Member]
Oct. 14, 2008
Predecessor [Member]
Cash flows from operating activities:          
Net income (loss) $ (2,000) $ (120,000) $ (89,487) $ (9,611,972) $ 65,332
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization 50,000 826,000 2,161,486 1,103,732 9,691
(Gain) loss on impairment of intangible assets     0 8,038,431 0
Provision for allowance for inventory valuation 0 (107,000) (146,266) (129,152) 27,363
Noncash interest expense 22,000 16,000 159,780 19,707 9,500
Stock option compensation expense 73,000 72,000 39,528 97,311 0
(Increase) decrease in accounts receivable 488,000 (913,000) (397,996) (572,854) 1,049,802
(Increase) decrease in inventory (net of progress billed) (253,000) 1,145,000 (2,483,686) 2,253,247 (863,566)
(Increase) decrease in other current assets 183,000 118,000 196,633 86,352 18,541
(Increase) decrease in deferred tax asset (net of valuation allowance) 378,000 (243,000) (711,177) (282,319) 0
Increase (decrease) in accounts payable and accrued expenses 143,000 (1,806,000) 733,453 (1,831,205) (186,051)
Increase (decrease) in accrued warranty costs 0 (57,000) (145,470) (56,530) 0
Increase (decrease) in due to parent     0 0 1,428
Increase (decrease) in accrued estimated loss on contracts (698,000) (17,000) 541,479 9,008 (15,304)
Increase (decrease) in income taxes payable     0 0 0
Total adjustments 386,000 (966,000) (52,236) 8,735,728 51,404
Net cash (used)/provided by operating activities 384,000 (1,087,000) (141,723) (876,244) 116,736
Cash flows from investing activities:          
Cash received through Optex Texas acquisition     253,581 0 0
Purchased of property and equipment (25,000) (8,000) (13,824) (115,703) (13,338)
Net cash (used in) provided by investing activities (25,000) (8,000) 239,757 (115,703) (13,338)
Cash flows from financing activities:          
Private placement net of stock issuance cost     1,024,529 0 0
Proceeds from/(Repayments to) credit facility (net) (707,000) 959,000 0 1,106,852 0
Proceeds from loans payable 0 250,000 (207,265) 250,000 (20,000)
Repayments on loans payable 0 (250,000) 0 (250,000) 0
Net cash (used In) provided by financing activities (707,000) 959,000 817,264 1,106,852 (20,000)
Net increase (decrease) in cash and cash equivalents (348,000) (133,000) 915,298 114,905 83,398
Cash and cash equivalents at beginning of period 1,030,203 915,298 0 915,298 170,183
Cash and cash equivalents at end of period $ 682,000 $ 782,000 $ 915,298 $ 1,030,203 $ 253,581